agilon health, inc. (AGL)
NYSE: AGL · Real-Time Price · USD
2.820
+0.010 (0.36%)
Oct 22, 2024, 4:00 PM EDT - Market closed
Company Description
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States.
It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month.
The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc.
in March 2021. agilon health, inc.
was founded in 2016 and is based in Austin, Texas.
agilon health, inc.
| Country | United States |
| Founded | 2016 |
| IPO Date | Apr 15, 2021 |
| Industry | Medical Care Facilities |
| Sector | Healthcare |
| Employees | 1,117 |
| CEO | Steven Sell |
Contact Details
Address: 6210 East US Highway 290, Suite 450 Austin, Texas 78723 United States | |
| Phone | 562 256 3800 |
| Website | agilonhealth.com |
Stock Details
| Ticker Symbol | AGL |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $23.00 |
| CIK Code | 0001831097 |
| CUSIP Number | 00857U107 |
| ISIN Number | US00857U1079 |
| Employer ID | 37-1915147 |
| SIC Code | 8090 |
Key Executives
| Name | Position |
|---|---|
| Steven Jackson Sell | President, Chief Executive Officer and Director |
| Jeffrey Alan Schwaneke CPA | Executive Vice President and Chief Financial Officer |
| Girish Venkatachaliah | Chief Technology Officer |
| Benjamin Shaker | Chief Markets Officer |
| Timothy Gertsch | Vice President, Controller and Chief Accounting Officer |
| Leland Thomas | Senior Manager of Investor Relations |
| Denise Zamore | Chief Legal Officer and Secretary |
| Claire Mulhearn | Chief Communications and Public Affairs Officer |
| Mat Varghese | Chief People Officer |
| Bill Farry | Chief of Technology Innovation |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 10, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Aug 6, 2024 | 10-Q | Quarterly Report |
| Aug 6, 2024 | 8-K | Current Report |
| Jun 5, 2024 | 8-K | Current Report |
| Jun 3, 2024 | 8-K | Current Report |
| May 7, 2024 | 10-Q | Quarterly Report |
| May 7, 2024 | 8-K | Current Report |
| Apr 18, 2024 | ARS | Filing |
| Apr 18, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 18, 2024 | DEF 14A | Other definitive proxy statements |